Medicare Director Meena Seshamani on CMS’ New Drug Pricing Powers
Medicare’s historic plan to slow prescription drug spending is taking shape. Last Thursday federal health officials began detailing how one of two major drug price reforms contained in the Inflation Reduction Act will work and who it will affect.
This week, we talk with Medicare director Meena Seshamani about the “opportunity of a lifetime” to put these unprecedented policies into action.
Meena Seshamani, MD, PhD, Director of the Center for Medicare and Deputy Administrator, Centers for Medicare and Medicaid Services
Learn more and read a full transcript on our website.
Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.
Support this type of journalism today, with a gift.
Follow us on Twitter.
Hosted on Acast. See acast.com/privacy for more information.